iRadimed
IRMD
61 hedge funds and large institutions have $140M invested in iRadimed in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
15% more capital invested
Capital invested by funds: $122M → $140M (+$18.2M)
13% more funds holding
Funds holding: 54 → 61 (+7)
0.36% more ownership
Funds ownership: 38.42% → 38.78% (+0.36%)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.18M |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$898K |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$416K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$352K |
| 5 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$276K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$2.87M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$609K |
| 3 |
Renaissance Technologies
New York
|
-$587K |
| 4 |
Morgan Stanley
New York
|
-$541K |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$496K |
IRMD Hedge Fund Activity: Q2 2021 in Review
61 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2021, worth a combined $140M — up 15% from $122M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new IRMD positions and 4 closed out — a net gain of 7 holders — while 17 added to existing stakes and 24 trimmed.
The largest buyer was Vanguard Group, adding an estimated $5.18M. The largest seller was Russell Investments Group, cutting an estimated $2.87M.
- 61 institutional investors held iRadimed (IRMD) as of Q2 2021, up from 54 in Q1 2021.
- Funds reported $140M of iRadimed stock for Q2 2021, up 15% quarter-over-quarter.
- 11 funds opened new iRadimed positions in Q2 2021 and 4 closed out, a net change of +7 holders.
- The largest iRadimed buyer in Q2 2021 was Vanguard Group, an estimated $5.18M added.
- The largest iRadimed seller in Q2 2021 was Russell Investments Group, an estimated $2.87M sold.
Based on aggregated 13F filings for Q2 2021.